Speaker Profile
Ph.D., Director of R&D, One BioMed
Biography
Dr. Elian Rakhmanaliev is currently leading RD team at One BioMed, a biotechnological company, developing automated cartridgebased nucleic acid extraction instruments and kits. Elian has over 20 years of international academic and industrial experience and expertise in molecular diagnostics, genetics, and molecular biology. For the past 12 years his main focus was on developing NGS, qPCR and IAbased IVD tests, platforms and POCT devices for molecular diagnostics as well as nucleic acid extraction systems. Elian obtained his PhD in Genetics from Vavilov Institute of General Genetics and completed postdoctoral fellowships in Oncology at Karolinska Institute and in Immunogenetics at Johns Hopkins University.
Talk
Accelerating and simplifying nucleic acid extraction.
Introducing an automated microfluidic allinone nucleic acid extraction system developed based on a novel reversable chemical binding reaction. The integrated platform and cartridges enable gentle and rapid isolation of nucleic acid (including ultraHMW DNA) from various sample types or a wide range of research as well as clinical applications.
Clinical & Research Tools Showcase:
One BioMed
One BioMed is a molecular life science company at the forefront of innovation, accelerating the pace of biomedical research through implementation of cutting-edge technologies in developing of instruments and reagents for nucleic acid extraction and testing.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
